Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Celyad Oncology (CYAD)

Celyad Oncology SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYAD
DateTimeSourceHeadlineSymbolCompany
04/04/202406:00Business WireCelyad Oncology publie ses résultats financiers pour l'année 2023 ainsi que les récents évènements marquantsNASDAQ:CYADCelyad Oncology SA
04/04/202406:00Business WireCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CYADCelyad Oncology SA
08/02/202421:01Business WireCelyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SECNASDAQ:CYADCelyad Oncology SA
08/02/202421:01Business WireCelyad Oncology Announces Intention to Terminate SEC Reporting ObligationsNASDAQ:CYADCelyad Oncology SA
17/01/202411:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
16/01/202421:01Business WireCelyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 OutlookNASDAQ:CYADCelyad Oncology SA
16/01/202421:01Business WireCelyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024NASDAQ:CYADCelyad Oncology SA
21/12/202311:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
20/12/202321:01Business WireCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
20/12/202321:01Business WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/12/202321:01Business WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
15/12/202321:01Business WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
04/12/202313:34Business WireCelyad Announces Management ChangeNASDAQ:CYADCelyad Oncology SA
04/12/202313:34Business WireCelyad annonce un changement de directionNASDAQ:CYADCelyad Oncology SA
30/11/202321:01Business WireCelyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA (Article 14 §1 de la loi du 2 mai 2007)NASDAQ:CYADCelyad Oncology SA
30/11/202321:01Business WireCelyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
21/11/202321:00Business WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
21/11/202321:00Business WireCelyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/11/202321:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
14/11/202321:00Business WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
14/11/202321:00Business WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
09/11/202306:00Business WireCelyad Oncology publie ses résultats financiers pour le troisième trimestre de 2023 ainsi que ses récentes avancéesNASDAQ:CYADCelyad Oncology SA
09/11/202306:00Business WireCelyad Oncology reports third quarter 2023 financial results and recent business highlightsNASDAQ:CYADCelyad Oncology SA
27/10/202318:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
25/09/202321:01Business WireCelyad Oncology Announces the Termination of Its American Depository Receipt ProgramNASDAQ:CYADCelyad Oncology SA
25/09/202321:01Business WireCelyad Oncology annonce l’arrêt de son programme d’American Depositary ReceiptNASDAQ:CYADCelyad Oncology SA
18/09/202311:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
15/09/202321:01Business WireCelyad Oncology SA : Publication d’une notification de transparence rectifiée de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/09/202321:01Business WireCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
13/09/202311:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
 Showing the most relevant articles for your search:NASDAQ:CYAD

Your Recent History

Delayed Upgrade Clock